Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Lipidology|January 19, 2016
Non-high-density lipoprotein cholesterol: current status as cardiovascular markerRutger Verbeek, G Kees Hovingh, S Matthijs BoekholdtEuropean Journal of Pharmacology|May 20, 2015
PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemiaRutger Verbeek, Robert M Stoekenbroek, G Kees HovinghAtherosclerosis|December 22, 2016
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population studyNicolas Perrot, Rutger Verbeek, Manjinder Sandhu, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2016
Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief ReportRutger Verbeek, Marjorie Boyer, S Matthijs Boekholdt, et al.Journal of Clinical Lipidology|March 19, 2018
Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular diseaseSimone L Verweij, Maurice W J de Ronde, Rutger Verbeek, et al.Journal of Lipid Research|February 2, 2016
Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population StudyRutger Verbeek, S Matthijs Boekholdt, Robert M Stoekenbroek, et al.Journal of Clinical Lipidology|March 27, 2019
A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease riskRutger Verbeek, Federico Oldoni, R Preethi Surendran, et al.European Heart Journal|June 23, 2018
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention settingRutger Verbeek, Renate M Hoogeveen, Anne Langsted, et al.Journal of Clinical Lipidology|September 26, 2018
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population studyJulian C van Capelleveen, Sang-Rok Lee, Rutger Verbeek, et al.Heart (British Cardiac Society)|May 8, 2021
Lipoprotein(a) is robustly associated with aortic valve calciumYannick Kaiser, Sunny S Singh, Kang H Zheng, et al.Pageof 1